Stephen Pianko
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Feasibility and acceptability of pharmacist-led remote patient monitoring for carvedilol dose titration in clinically significant portal hypertension.
Journal: International journal of clinical pharmacy
Published: March 13, 2026
A Prospective, Cross-Sectional, Multicenter Study Evaluating a Multi-Target Blood Protein in Vitro Diagnostic Test for Colorectal Cancer.
Journal: Journal of gastrointestinal cancer
Published: December 07, 2025
Pilot phase clinical trial of a wearable, electrochemical aptamer-based patch for continuous drug concentration measurement.
Journal: Nature biotechnology
Published: April 23, 2025
Identify, screen and treat via electronic pathway: a semiautomated approach to retriaging a liver clinic waitlist.
Journal: Internal medicine journal
Published: January 14, 2024
Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network.
Journal: Internal medicine journal
Published: February 15, 2022
Short-term intraperitoneal catheters: An ambulatory care intervention for refractory ascites secondary to cirrhosis during COVID-19.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: May 08, 2021
Very Delayed Acute Hepatitis after Pembrolizumab Therapy for Advanced Malignancy: How Long Should We Watch?
Journal: Current oncology (Toronto, Ont.)
Published: January 14, 2021
Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 03, 2019
Immunomodulator use does not prevent first loss of response to anti-tumour necrosis factor alpha therapy in inflammatory bowel disease: long-term outcomes in a real-world cohort.
Journal: Internal medicine journal
Published: May 14, 2018
Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.
Journal: Hepatology (Baltimore, Md.)
Published: September 14, 2017
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 29, 2017
Last Updated: 09/26/2026